QuintilesIMS in alliance with Salesforce

QuintilesIMS, provider of information, technology services and contract research to the life sciences industry, announced an alliance with Salesforce, the world’s #1 CRM company and Intelligent Customer Success Platform, to offer life sciences companies new capabilities to move treatments more efficiently and effectively, from molecule to market.

As part of the alliance, QuintilesIMS is building new solutions on the Salesforce Platform, taking advantage of built-in cloud, mobile, social and artificial intelligence (AI) capabilities. These solutions — in addition to other products QuintilesIMS builds on the Salesforce Marketing Cloud — will help life science companies better manage clinical trials, accelerate patient recruitment, improve efficiency and effectiveness of marketing activities, as well as achieve other key commercial objectives as they bring new therapies to market and beyond.

Keith Block, Vice Chairman, President and COO, Salesforce said, "Building on the Salesforce Intelligent Customer Success Platform, QuintilesIMS will create solutions that empower life sciences firms to collaborate with providers and patients, in smarter and more predictive ways, throughout the clinical life cycle."

"This Salesforce collaboration furthers our strategy of building our solutions on a foundation of intelligent, technology-standard platforms. Using this approach, as well as continuous updates provided by the platform providers, we can better focus on our areas of differentiation, which deliver the greatest value and benefit to our customers," said Kevin Knightly, President, Information & Technology Solutions, QuintilesIMS.

While terms of the agreement have not been disclosed, it is a multi-year venture that will operate on a global scale.